XLK dropped 4.1% on Tuesday to $184.19, yet for the first time in weeks, short sellers are not pressing into the weakness — they are stepping back.
The shift in positioning is the most interesting development this week. Short interest pulled back 7% in a single session on June 23, falling to 5.76% of free float from a peak of roughly 6.3% the prior day. That one-day trim is a meaningful reversal from a build that had run almost continuously for two months, adding 25% cumulatively since late May. The ORTEX short score eased to 43.3 from 47.1 the previous day, though it remains well above the 34.7 reading from two weeks ago. Bears are not abandoning the position — the month-on-month increase is still nearly 25% — but the reflexive adding-into-strength pattern that defined the past six weeks showed its first crack on a down day.
The borrow market corroborates that partial retreat. Availability has loosened sharply, jumping back to 267% from 164% the day before — a 62% improvement in a single session. That puts availability back near the middle of its recent range, well clear of the 41% 52-week floor. Borrowing costs, which had climbed from sub-0.50% in May to a peak near 0.96% on June 22, pulled back to 0.81% on Tuesday. Costs are still roughly 63% above their one-month average — a sign that borrow demand has genuinely risen over the period — but the direction of travel on both cost and availability now points toward modest easing rather than continued tightening.
Options positioning tells a different story from the short book, and the divergence is worth flagging. The put/call ratio has dropped to 1.50, nearly two standard deviations below its 20-day average of 1.90. That is the lowest PCR reading in roughly a year, close to the 52-week floor of 1.34, and represents a sharp unwind of the heavy put positioning that dominated the prior six weeks. Options traders are hedging less aggressively, even as short interest remains elevated and the stock just logged its worst single-day move in months. The two positioning signals are pulling in opposite directions: the short book says caution, the options market says the tail risk is being priced down.
Institutional ownership adds some ballast to the picture. The top holders are mostly wealth-management platforms and large broker-dealers — Wells Fargo, Morgan Stanley, LPL, UBS — rather than directional funds, which is typical for an ETF of this size. UBS Asset Management added the most aggressively in the most recent 13F period, building a position by 3.4 million shares through March, while LPL and Focus Partners trimmed modestly. None of these moves point to a fundamental shift in the long base, and the 436-holder count is consistent with broad, sticky ownership. The context matters because it limits how disruptive a short squeeze would be: the lending pool is still large relative to the short position, and the holders are not natural forced sellers.
The question heading into next week is whether Tuesday's short-covering holds or was a one-session anomaly. Six weeks of continuous building followed by a single day of trimming on the first material down-move is not yet a trend reversal. The ORTEX short score at 43.3 sits higher than it did at any point in May or early June — the regime has changed even if this week saw a pause. Whether the PCR's sudden optimism and the short book's residual caution converge or diverge further is the tension worth tracking.
See the live data behind this article on ORTEX.
Open XLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
